| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3187087 | Annales de Dermatologie et de Vénéréologie | 2012 | 4 Pages |
Abstract
In case of intolerance to IM, a second-generation ITK (dasatinib or nilotinib) may be substituted, and while cross-sensitivities seem infrequent, therapy is problematic in these patients presenting potentially curable blood dyscrasias.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
M. Lamchahab, M. Qachouh, F. Hali, H. Benchikhi, A. Quessar, S. Benchekroun,